- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
Flora Growth Corp (FLGC)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
01/28/2026: FLGC (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $30
1 Year Target Price $30
| 1 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 5.81M USD | Price to earnings Ratio - | 1Y Target Price 30 |
Price to earnings Ratio - | 1Y Target Price 30 | ||
Volume (30-day avg) 2 | Beta 1.87 | 52 Weeks Range 5.86 - 47.00 | Updated Date 01/31/2026 |
52 Weeks Range 5.86 - 47.00 | Updated Date 01/31/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -41.09 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -27.7% | Operating Margin (TTM) -33.5% |
Management Effectiveness
Return on Assets (TTM) -17.55% | Return on Equity (TTM) -45.26% |
Valuation
Trailing PE - | Forward PE 7.89 | Enterprise Value 19146760 | Price to Sales(TTM) 0.37 |
Enterprise Value 19146760 | Price to Sales(TTM) 0.37 | ||
Enterprise Value to Revenue 0.37 | Enterprise Value to EBITDA -1 | Shares Outstanding 741261 | Shares Floating 613514 |
Shares Outstanding 741261 | Shares Floating 613514 | ||
Percent Insiders 16.61 | Percent Institutions 2.05 |
Upturn AI SWOT
Flora Growth Corp

Company Overview
History and Background
Flora Growth Corp. was founded in 2019 with the vision of becoming a leading global indoor cannabis cultivator. Its primary focus has been on developing and operating state-of-the-art, sustainable indoor cultivation facilities in North America. A significant milestone was its public listing on the Nasdaq stock exchange, providing capital for expansion. The company has evolved by expanding its product offerings beyond raw cannabis to include derivatives and wellness products.
Core Business Areas
- Cannabis Cultivation and Production: Flora Growth Corp. operates high-tech, controlled-environment agriculture (CEA) facilities designed for the sustainable and efficient cultivation of high-quality cannabis. This segment focuses on producing biomass for various applications and developing proprietary cultivation methods.
- Cannabis Derivatives and Finished Products: This segment involves the extraction of cannabinoids from cultivated cannabis and their incorporation into a range of finished products. This includes oils, tinctures, and potentially other consumer goods leveraging the therapeutic and wellness properties of cannabis compounds.
- E-commerce and Direct-to-Consumer (DTC): Flora Growth Corp. aims to leverage e-commerce platforms to reach consumers directly with its product offerings. This strategy allows for greater control over brand messaging and customer relationships.
Leadership and Structure
Flora Growth Corp. is led by a management team with experience in cultivation, biotechnology, and business development. The organizational structure is designed to support its cultivation operations, product development, and market expansion strategies. Specific leadership details (CEO, CFO, etc.) and their bios would typically be found in their investor relations materials.
Top Products and Market Share
Key Offerings
- Description: Cultivated cannabis biomass from Flora's controlled environments, intended for extraction and use in downstream products. Market share data is difficult to ascertain for this specific product category for Flora alone, as it is often an ingredient. Key competitors in cannabis cultivation include Cronos Group (CRON), Canopy Growth (WEED), Tilray (TLRY), and numerous private cultivators.
- Product Name 1: High-Quality Cannabis Biomass
- Description: Finished consumer products containing cannabinoids, marketed for various wellness applications. Market share in this segment is highly fragmented. Competitors include a vast array of established and emerging cannabis brands, as well as companies in the broader health and wellness sector.
- Product Name 2: Cannabis-Derived Wellness Products (e.g., Oils, Tinctures)
Market Dynamics
Industry Overview
The cannabis industry is dynamic and rapidly evolving, marked by increasing legalization in various jurisdictions, growing consumer acceptance, and significant investment. Key trends include the shift towards medicinal and recreational use, development of novel product formats, and a focus on sustainable and scientific cultivation practices. Regulatory changes and market access remain critical factors.
Positioning
Flora Growth Corp. positions itself as a leader in sustainable, high-tech cannabis cultivation. Its competitive advantages lie in its proprietary cultivation technology, focus on quality control, and strategy to integrate cultivation with downstream product development and direct-to-consumer sales. The company aims to differentiate through efficiency and sustainability.
Total Addressable Market (TAM)
The global cannabis market is substantial and projected to grow significantly. While precise TAM figures vary by source and scope (e.g., including medical, recreational, CBD), estimates often range in the tens of billions of dollars, with significant expansion anticipated over the next decade. Flora Growth Corp. is positioned to capture a portion of this TAM through its cultivation and product development capabilities, particularly in markets where it has regulatory access and can leverage its efficient production model.
Upturn SWOT Analysis
Strengths
- State-of-the-art, sustainable cultivation facilities
- Proprietary cultivation technologies
- Focus on quality and consistency
- Vertical integration strategy (cultivation to product)
- Experienced management team
Weaknesses
- Brand recognition and market penetration challenges in a crowded market
- Dependence on regulatory changes and market access
- Historically high operational costs and cash burn
- Limited historical financial track record compared to established players
- Potential challenges in scaling production rapidly and cost-effectively
Opportunities
- Expansion into new and emerging cannabis markets
- Development of new cannabinoid-based wellness products
- Strategic partnerships and acquisitions
- Growth in the global CBD market
- Increased consumer demand for sustainable products
Threats
- Intensifying competition from domestic and international players
- Unfavorable regulatory shifts or policy changes
- Price compression due to oversupply
- Challenges in international market entry and compliance
- Economic downturns impacting consumer spending
Competitors and Market Share
Key Competitors
- Cronos Group (CRON)
- Canopy Growth Corporation (WEED)
- Tilray Brands, Inc. (TLRY)
- Aurora Cannabis Inc. (ACB)
Competitive Landscape
Flora Growth Corp. faces a highly competitive landscape dominated by larger, more established players with greater financial resources and brand recognition. Its advantages lie in its focus on advanced cultivation technology and sustainability, which could appeal to specific market segments. However, it faces disadvantages in terms of scale, capital, and immediate market penetration compared to its larger rivals.
Growth Trajectory and Initiatives
Historical Growth: Flora Growth Corp. has demonstrated historical growth in revenue as it has brought its cultivation facilities online and expanded its product portfolio. The company has focused on building its operational capacity and market presence since its inception. Revenue growth figures would show an upward trend as operations mature.
Future Projections: Future growth projections for Flora Growth Corp. are contingent on its ability to successfully scale its operations, gain market share in its target geographies, and effectively launch new products. Analyst estimates would likely project continued revenue growth, with an eventual path towards profitability as operations become more efficient and economies of scale are realized. The company's expansion into new product categories and markets will be key drivers.
Recent Initiatives: Recent initiatives likely include the expansion of cultivation capacity, the development and launch of new consumer product lines, exploring new geographic markets, and potentially seeking strategic partnerships or acquisitions to accelerate growth and market access.
Summary
Flora Growth Corp. is an emerging player in the cannabis industry, focused on advanced cultivation and product development. The company has shown revenue growth but faces significant competition and has yet to achieve consistent profitability. Its strengths lie in its technological approach to cultivation and sustainability, while its weaknesses include brand recognition and financial scale. Continued strategic execution, market access, and efficient operations will be crucial for its future success.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company filings (SEC)
- Industry reports
- Financial news outlets
- Market data providers
Disclaimers:
This JSON output is based on publicly available information and general industry knowledge as of the last update. It is not investment advice. Financial data and market share figures are estimates and subject to change. Investors should conduct their own due diligence.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Flora Growth Corp
Exchange NASDAQ | Headquaters Fort Lauderdale, FL, United States | ||
IPO Launch date 2021-05-11 | CEO & Director Mr. Daniel Reis-Faria | ||
Sector Financial Services | Industry Asset Management | Full time employees 64 | Website https://zerostack.ai |
Full time employees 64 | Website https://zerostack.ai | ||
Flora Growth Corp. operates as an AI-powered asset management company focused on providing decentralized AI. In addition, it engages in the distribution of pharmaceutical goods and medical cannabis products to treat a range of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. Flora Growth Corp. was incorporated in 2019 and is headquartered in Fort Lauderdale, Florida.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 
